Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06408389Not Yet Recruiting

Mechanics of Human Pre Implantation Development

Role: collaborator

NCT02671864Not ApplicableUnknown

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Role: collaborator

NCT03986853Not ApplicableTerminated

Exploration of Angiogenesis in Decompensated Developmental Venous Abnormalities

Role: collaborator

All 3 trials loaded